NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

4 - Duncan Charles Cliff

Filed: 2026-04-24 AccNo: 0002130896-26-000008 Size: 4 KB
查看原文来源主页查看事件簇按来源查看
发布时间04/24 20:36 UTC
首次发现04/24 20:39 UTC
热度106.3
重要度74
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 477 字符

Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0002130896-26-000008

Filing Date: 2026-04-24

Accepted: 2026-04-24 16:36:42

Documents: 1

Period of Report: 2026-04-22

Vanda Pharmaceuticals Inc. ( Issuer ) CIK : 0001347178 (see all company filings) EIN. : 030491827 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 4 | ownership.html | 4

1 | 4 | ownership.xml | 4